Floatz logo

Romiplostim

Solid Tumor, Childhood

Memorial Sloan Kettering Cancer Centerprotein_peptidePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Solid Tumor, Childhood cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
City of Hope Medical Center
Phase 2/3BBB
FILGRASTIM
Barbara Ann Karmanos Cancer Institute
Phase 3BBB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 2/3BBB
Carboplatin
Seoul National University Hospital
Phase 2/3BBB
Irinotecan
EpicentRx, Inc.
Phase 2BBB

View all 50 →

Same molecule, other indications

Romiplostim is also rated in:

ThrombocytopeniaDormant
BB
Indicative ·
70 / 100
View asset →
thrombocytopeniaDormant
BB
Indicative ·
65 / 100
View asset →
neoplasmDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →